Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil. | Zendy

C. E. Angermann | Zendy; C Spes | Zendy; Sara M. Willems | Zendy; Peter Dominiak | Zendy; B. M. Kemkes | Zendy; K. Theisen | Zendy

Open Access

Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil.

Author(s) -

C. E. Angermann,

C Spes,

Sara M. Willems,

Peter Dominiak,

B. M. Kemkes,

K. Theisen

Publication year - 1991

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.84.2.583

Subject(s) - medicine , enalapril , cardiology , furosemide , left ventricular hypertrophy , verapamil , muscle hypertrophy , diastole , blood pressure , hemodynamics , supine position , heart transplantation , ambulatory , heart failure , angiotensin converting enzyme , calcium

This prospective study was designed to examine whether left ventricular (LV) hypertrophy of the denervated transplanted heart may be reversed by medical therapy and, if so, to investigate the time course of this process and its effect on exercise capacity, myocardial function, and cardiac hemodynamics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research